Table 2.
Scenario | N° of trials (%) (total = 42) | N° of comparisons (%) (total = 81) |
---|---|---|
A) statistically significant and clinically relevant |
15 (36%) | 20 (25%) |
B) statistically significant but not clinically relevant |
10 (24%) | 22 (27%) |
C) not statistically significant but clinically relevant |
1 (2%) | 1 (1%) |
D) not statistically significant and not clinically relevant |
16 (38%) | 38 (47%) |